HeimU2TH34 • BVMF
add
United Therapeutics Corp Bdr
Við síðustu lokun
131,04 R$
Dagbil
130,93 R$ - 131,04 R$
Árabil
77,40 R$ - 144,09 R$
Markaðsvirði
21,85 ma. USD
V/H-hlutf.
-
A/V-hlutfall
-
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | des. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 790,20 m. | 7,38% |
Rekstrarkostnaður | 331,30 m. | 11,14% |
Nettótekjur | 364,30 m. | 20,91% |
Hagnaðarhlutfall | 46,10 | 12,60% |
Hagnaður á hvern hlut | 7,70 | 24,39% |
EBITDA | 378,30 m. | -0,86% |
Virkt skatthlutfall | 17,95% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | des. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 2,92 ma. | -10,61% |
Heildareignir | 7,88 ma. | 7,01% |
Heildarskuldir | 783,80 m. | -14,80% |
Eigið fé alls | 7,10 ma. | — |
Útistandandi hlutabréf | 43,83 m. | — |
Eiginfjárgengi | 0,81 | — |
Arðsemi eigna | 11,67% | — |
Ávöxtun eigin fjár | 12,95% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | des. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | 364,30 m. | 20,91% |
Handbært fé frá rekstri | 346,20 m. | 1,47% |
Reiðufé frá fjárfestingum | -227,60 m. | -84,74% |
Reiðufé frá fjármögnun | 98,40 m. | 231,73% |
Breyting á handbæru fé | 217,00 m. | 51,43% |
Frjálst peningaflæði | 60,35 m. | -71,66% |
Um
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
Stofnsett
1996
Höfuðstöðvar
Vefsvæði
Starfsfólk
1.400
